EPISODE · Sep 8, 2025 · 30 MIN
Rich Shea | CEO, Basking Biosciences – RNA Aptamers for Acute Thrombosis Treatment
from Executive Insights for Life Sciences Innovators · host GeneCoda® Executive Search
In this episode of Executive Insights for Life Sciences Innovators, we sit down with Rich Shea, CEO of Basking Biosciences, to discuss the company’s pioneering work with RNA aptamer technology for the treatment of acute thrombosis. Rich shares insights on Basking’s scientific journey, the challenges of advancing a novel therapeutic approach, and the opportunities ahead in cardiovascular care.Learn more at genecoda.com.Originally recorded and streamed on YouTube Live on February 24, 2025.
What this episode covers
In this episode of Executive Insights for Life Sciences Innovators, we sit down with Rich Shea, CEO of Basking Biosciences, to discuss the company’s pioneering work with RNA aptamer technology for the treatment of acute thrombosis. Rich shares insights on Basking’s scientific journey, the challenges of advancing a novel therapeutic approach, and the opportunities ahead in cardiovascular care.Learn more at genecoda.com.Originally recorded and streamed on YouTube Live on February 24, 2025.
NOW PLAYING
Rich Shea | CEO, Basking Biosciences – RNA Aptamers for Acute Thrombosis Treatment
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m